Espee Therapeutics LLP - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
LLPIN AAH-8938 Incorporated 25 November 2016 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership pharma MSME
Revenue · FY 2021
₹13.65 Cr
▲ 80% YoY
Net profit · FY 2021
₹3.78 Cr
Net margin 27.7%
EBITDA · FY 2021
₹13.99 Cr
EBITDA margin 102.4%
Contribution obligation
₹1 Cr
As per LLP agreement
Open charges
₹1.07 Cr
Satisfied ₹10.24 Cr
LLP age
10 yrs
Est. 2016
Employees · EPFO
21
Provident fund records
Designated partners
2
As per MCA filings

About Espee Therapeutics LLP

Data last updated:

Espee Therapeutics LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 November 2016 and has been in existence for over 10 years.

Its director Swapnil Jatin Shah is #1,233 among India's richest people (2026).

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAH-8938. Its GSTIN is 24AAGFE1071K1ZM (Gujarat).

The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners Swapnil Jatinbhai Shah and Anar Swapnil Shah.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Jayantilal Park, Ahmedabad, Gujarat.

As per the financials filed for FY 2021, the LLP reported a revenue of ₹13.65 Cr, a growth of 80% compared to the previous year. For the same year it recorded a net profit of ₹3.78 Cr (net margin 27.7%) and EBITDA of ₹13.99 Cr (EBITDA margin 102.4%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years.

The LLP has about 21 employees on its provident fund (EPFO) records.

As per MCA filings, the LLP has open charges of ₹1.07 Cr and satisfied charges of ₹10.24 Cr on record. Court records list 1 case involving the LLP, including 1 filed against it.

Espee Therapeutics LLP is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0027656). For more details, the LLP can be reached via its website espeelife.com.

Company details

LLPIN AAH-8938
Incorporation Date 25 November 2016
Total Obligation of Contribution ₹1 Cr
ROC Ahmedabad
Company Status Active
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0027656

Recognitions & Rankings of Espee Therapeutics

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-GJ-01-0027656
India's Richest People 2026 edition · 1 director · Source: Hurun India

Contact details

Espee Therapeutics LLP's registered office is in Ahmedabad, Gujarat. Its website is espeelife.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    S.T. 1101 One 42 B/H. Ashok Vatika Nr. Jayantilal Park Brts Ambli Bopal Ro, Ad, Ahmedabad, Gujarat, India – 380054
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Espee Therapeutics LLP, buy the company report.

Comprehensive company report
Espee Therapeutics LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Espee Therapeutics LLP

FY 2025 filings available

Espee Therapeutics LLP reported revenue of ₹13.65 Cr (up 80% YoY) for FY 2021.

Revenue · FY 2021
₹13.65 Cr ▲ 80%
Net profit · FY 2021
₹3.78 Cr margin 27.7%
EBITDA · FY 2021
₹13.99 Cr margin 102.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 95%
3 years · compounded
▲ 55%

Revenue has grown at a compounded annual rate (CAGR) of 57% over three years, including 80% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Income and Expenditure
Turnover₹13.65 Cr
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹3.78 Cr
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
Net Profit Margin27.7%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Espee Therapeutics LLP, buy the company report.

Designated partners of Espee Therapeutics LLP

Espee Therapeutics has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Swapnil Jatinbhai ShahDesignated Partner25 Nov 20169 Years 11 MonthsCurrent
Anar Swapnil ShahDesignated Partner25 Nov 20169 Years 11 MonthsCurrent

Auditor

Espee Therapeutics LLP is audited by PARIKH & MAJMUDAR for the financial year 2021.

Auditor firmFinancial yearFirm registration number
PARIKH & MAJMUDARFY 2021107525W

Charges & borrowings

Open charges
₹1.07 Cr
Satisfied charges
₹10.24 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹1.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Nov 2025101191230Hdfc Bank Limited₹32.08 LakhOpen
06 May 2024100927643Hdfc Bank Limited₹20 LakhOpen
16 Nov 2023100818907Hdfc Bank Limited₹55 LakhOpen
05 Apr 2023100710513Icici Bank Limited₹2.45 CrSatisfied
15 Jan 2021100429089Icici Bank Limited₹7.79 CrSatisfied

To see the full charge records of Espee Therapeutics LLP, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Espee Therapeutics LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Espee Therapeutics LLP has a workforce of 21 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
21
Active EPFO establishments
1
Employee growth
23.5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2721
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Espee Therapeutics LLP, buy the company report.

GST

Espee Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAGFE1071K1ZMGujaratActive12 Jul 2017

To see the full GST registrations and return filing status of Espee Therapeutics LLP, buy the company report.

Recent activity

Espee Therapeutics LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Anar Swapnil Shah was appointed as Designated Partner on 25 Nov 2016.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 101191230 was registered on 26 Nov 2025.
AGM
Espee Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Espee Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 15 Jan 2021 via Charge ID 100429089 with Icici Bank Limited was fully satisfied on 04 Sep 2024.
Charges
A charge registered on 05 Apr 2023 via Charge ID 100710513 with Icici Bank Limited was fully satisfied on 02 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100927643 was registered on 06 May 2024.
Charges
A charge with Icici Bank Limited of Rs. 7.79 Cr registered on 15 Jan 2021 with Charge ID 100429089 was modified on 13 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.55 Cr with Charge ID 100818907 was registered on 16 Nov 2023.
Charges
A charge with Icici Bank Limited amounted to Rs. 2.45 Cr with Charge ID 100710513 was registered on 05 Apr 2023.
Charges
A charge with Icici Bank Limited amounted to Rs. 7.79 Cr with Charge ID 100429089 was registered on 15 Jan 2021.
Appointed
Anar Swapnil Shah was appointed as Designated Partner.
Appointed
Swapnil Jatinbhai Shah was appointed as Designated Partner.

1 earlier event is in the company report.

Frequently asked questions

Espee Therapeutics is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 November 2016 (10+ years old) and is registered under LLPIN AAH-8938.

Espee Therapeutics has 2 current designated partners:

The latest financial statements of Espee Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Espee Therapeutics is 24AAGFE1071K1ZM, registered in Gujarat.

The LLPIN (Limited Liability Partnership Identification Number) of Espee Therapeutics is AAH-8938. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Espee Therapeutics has 1 court case on record: 1 filed against it.

Espee Therapeutics was incorporated on 25 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Anar Swapnil Shah was appointed as Designated Partner on 25 Nov 2016. Swapnil Jatinbhai Shah was appointed as Designated Partner on 25 Nov 2016.

Yes, Espee Therapeutics is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0027656).

Espee Therapeutics can be reached through the website espeelife.com. Its registered office is in Ahmedabad, Gujarat, India.